CTLA4 and colitis: Enhanced colonic IL-6 was also seen in models of mice challenged with acute infection with Citrobacter rodentium or Dextran Sulfate Sodium (DSS) followed by anti-CTLA-4 administration (117), suggesting that IL-6 may serve as a cytokine signature in ICI-induced colitis (Figure 2).